Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cells|March 14, 2020
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib.Nicla Lorito, Marina Bacci, Alfredo Smiriglia, et al.
International Journal of Molecular Sciences|October 14, 2022
The TRPV1 Receptor Is Up-Regulated by Sphingosine 1-Phosphate and Is Implicated in the Anandamide-Dependent Regulation of Mitochondrial Activity in C2C12 MyoblastsSara Standoli, Sara Pecchioli, Daniel Tortolani, et al.
Hepatology (Baltimore, Md.)|August 21, 2023
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytesMarta A Kowalik, Keiko Taguchi, Marina Serra, et al.
EMBO Reports|June 21, 2024
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancerLuigi Ippolito, Assia Duatti, Marta Iozzo, et al.
EMBO Molecular Medicine|June 26, 2024
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancerNicla Lorito, Angela Subbiani, Alfredo Smiriglia, et al.
Molecular Oncology|June 26, 2025
Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinomaElisa Pardella, Giuseppina Comito, Luigi Ippolito, et al.
Cancer Research|February 9, 2022
Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate CancerLuigi Ippolito, Giuseppina Comito, Matteo Parri, et al.
Cell Reports|July 4, 2019
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast CancerMarina Bacci, Nicla Lorito, Luigi Ippolito, et al.
Cancer Research|November 7, 2025
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast CancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.
Gut|May 27, 2022
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancerMaria Chiara De Santis, Luca Gozzelino, Jean Piero Margaria, et al.
Pageof 3